Get started
Zealand Pharma A/SZealand Pharma A/SZealand Pharma A/S

Zealand Pharma A/S

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

ZLDPF chart


Full chart

ZLDPF upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪4.85 B‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
4.55
Basic EPS (TTM)
14.96 USD
Net income (FY)
‪−149.31 M‬ USD
Revenue (FY)
‪8.68 M‬ USD
Shares float
‪62.73 M‬
Beta (1Y)
0.83

Employees


Employees (FY)
335
Change (1Y)
+82 +32.41%
Revenue / Employee (1Y)
‪25.90 K‬ USD
Net income / Employee (1Y)
‪−445.70 K‬ USD

About Zealand Pharma A/S


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Adam Sinding Steensberg
Website
zealandpharma.com
Headquarters
Soborg
Founded
1997
ISIN
DK0060257814
FIGI
BBG00276D296
Zealand Pharma A/S is a biotechnology company, which engages in the discovery, design, and development of peptide based medicines. Its products include Zegalogue and V-Go. The company was founded by Lars Hellerung Christiansen and Bjarne Due Larsen on April 1, 1997 and is headquartered in Soborg, Denmark.

Check out other big names from the same industry as ZLDPF.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

ZLDPF news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of ZLDPF is 68.81 USD — it has increased by 4.26% in the past 24 hours. Watch Zealand Pharma A/S stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Zealand Pharma A/S stocks are traded under the ticker ZLDPF.
ZLDPF stock has risen by 11.40% compared to the previous week, the month change is a 27.17% rise, over the last year Zealand Pharma A/S has showed a −45.39% decrease.
We've gathered analysts' opinions on Zealand Pharma A/S future price: according to them, ZLDPF price has a max estimate of 175.39 USD and a min estimate of 62.64 USD. Watch ZLDPF chart and read a more detailed Zealand Pharma A/S stock forecast: see what analysts think of Zealand Pharma A/S and suggest that you do with its stocks.
ZLDPF reached its all-time high on Aug 16, 2024 with the price of 141.74 USD, and its all-time low was 10.20 USD and was reached on Nov 21, 2013. View more price dynamics on ZLDPF chart.
See other stocks reaching their highest and lowest prices.
ZLDPF stock is 4.08% volatile and has beta coefficient of 0.83. Track Zealand Pharma A/S stock price on the chart and check out the list of the most volatile stocks — is Zealand Pharma A/S there?
Today Zealand Pharma A/S has the market capitalization of ‪4.81 B‬, it has increased by 15.05% over the last week.
Yes, you can track Zealand Pharma A/S financials in yearly and quarterly reports right on TradingView.
Zealand Pharma A/S is going to release the next earnings report on Nov 13, 2025. Keep track of upcoming events with our Earnings Calendar.
ZLDPF earnings for the last quarter are 16.64 USD per share, whereas the estimation was 17.22 USD resulting in a −3.40% surprise. The estimated earnings for the next quarter are −1.27 USD per share. See more details about Zealand Pharma A/S earnings.
Zealand Pharma A/S revenue for the last quarter amounts to ‪1.43 B‬ USD, despite the estimated figure of ‪1.45 B‬ USD. In the next quarter, revenue is expected to reach ‪3.05 M‬ USD.
ZLDPF net income for the last quarter is ‪1.19 B‬ USD, while the quarter before that showed ‪−48.59 M‬ USD of net income which accounts for ‪2.56 K‬% change. Track more Zealand Pharma A/S financial stats to get the full picture.
No, ZLDPF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 1, 2025, the company has 335 employees. See our rating of the largest employees — is Zealand Pharma A/S on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Zealand Pharma A/S EBITDA is ‪1.17 B‬ USD, and current EBITDA margin is ‪−1.98 K‬%. See more stats in Zealand Pharma A/S financial statements.
Like other stocks, ZLDPF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Zealand Pharma A/S stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Zealand Pharma A/S technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Zealand Pharma A/S stock shows the neutral signal. See more of Zealand Pharma A/S technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.